Liver function tests
S.G.O.T.(ALT), S.G.P.T.(AST) | |
---|---|
ICD-10-PCS | K-70 to K-77 |
ICD-9-CM | 570–573 |
MeSH | D008111 |
MedlinePlus | 003436 |
Liver function tests (LFTs or LFs), also referred to as a hepatic panel, are groups of blood tests that provide information about the state of a patient's
Most
Several biochemical tests are useful in the evaluation and management of patients with hepatic dysfunction. These tests can be used to detect the presence of liver disease. They can help distinguish among different types of liver disorders, gauge the extent of known liver damage, and monitor the response to treatment. Some or all of these measurements are also carried out (usually about twice a year for routine cases) on individuals taking certain medications, such as anticonvulsants, to ensure that these medications are not adversely impacting the person's liver.[citation needed]
Standard liver panel
Standard liver tests for assessing liver damage include alanine aminotransferase (ALT), aspartate aminotransferase (AST), and alkaline phosphatases (APs). Bilirubin may be used to estimate the excretory function of the liver and coagulation tests and albumin can be used to evaluate the metabolic activity of the liver.[6]
Although example reference ranges are given, these will vary depending on method of analysis used at the administering laboratory, as well as age, gender, ethnicity, and potentially unrelated health factors. Individual results should always be interpreted using the reference range provided by the laboratory that performed the test.[citation needed]
Total bilirubin
Parameters/units | Total bilirubin | Unconjugated bilirubin | Conjugated bilirubin |
---|---|---|---|
mg/dL | 0.1–1.0[7] | 0.2–0.7[7] | 0.1–0.4[7] |
μmol/L | 2.0–21[6] | < 12[6] | < 8[6] |
Measurement of total
The increase in predominantly unconjugated bilirubin is due to overproduction, reduced hepatic uptake of the unconjugated bilirubin and reduced conjugation of bilirubin. Overproduction can be due to the reabsorption of a
The degree of rise in conjugated bilirubin is directly proportional to the degree of hepatocyte injury. Viral hepatitis can also cause the rise in conjugated bilirubin. In parenchymal liver disease and incomplete extrahepatic obstruction, the rise in conjugated bilirubin is less than the complete common bile duct obstruction due to malignant causes. In Dubin–Johnson syndrome, a mutation in multiple drug-resistance protein 2 (MRP2) causes a rise in conjugated bilirubin.[6]
In
The measurement of bilirubin levels in the newborns is done through the use of bilimeter or transcutanoeus bilirubinometer instead of performing LFTs. When the total serum bilirubin increases over 95th percentile for age during the first week of life for high risk babies, it is known as hyperbilirubinemia of the newborn (neonatal jaundice) and requires light therapy to reduce the amount of bilirubin in the blood. Pathological jaundice in newborns should be suspected when the serum bilirubin level rises by more than 5 mg/dL per day, serum bilirubin more than the physiological range, clinical jaundice more than 2 weeks, and conjugated bilirubin (dark urine staining clothes). Haemolytic jaundice is the commonest cause of pathological jaundice. Those babies with Rh hemolytic disease, ABO incompatibility with the mother, Glucose-6-phosphate dehydrogenase (G-6-PD) deficiency and minor blood group incompatibility are at increased risk of getting haemolytic jaundice.[8]
Alanine transaminase (ALT)
Reference range |
7-56 IU/L[6] |
Apart from being found in high concentrations in the liver, ALT is found in the kidneys, heart, and muscles. It catalyses the
In pregnancy, ALT levels would rise during the second trimester. In one of the studies, measured ALT levels in pregnancy-related conditions such as hyperemesis gravidarum was 103.5 IU/L, pre-eclampsia was 115, HELLP syndrome was 149. ALT levels would reduce by greater than 50% in three days after child delivery. Another study also shows that caffeine consumption can reduce the risk of ALT elevation in those who consume alcohol, overweight people, impaired glucose metabolism, and viral hepatitis.[6]
Aspartate transaminase (AST)
Reference range |
0-35 IU/L[6] |
AST exists in two
In certain pregnancy related conditions such as hyperemesis gravidarum, AST can reach as high as 73 IU/L, 66 IU/L in pre-eclampsia, and 81 IU/L in HELLP syndrome.[6]
AST/ALT ratio
The AST/ALT ratio increases in liver functional impairment. In alcoholic liver disease, the mean ratio is 1.45, and mean ratio is 1.33 in post necrotic liver cirrhosis. Ratio is greater than 1.17 in viral cirrhosis, greater than 2.0 in alcoholic hepatitis, and 0.9 in non-alcoholic hepatitis. Ratio is greater than 4.5 in
Alkaline phosphatase (ALP)
Reference range |
41 to 133 IU/L[6] |
ALP activity is significantly increased in the third trimester of pregnancy.[10] This is due to increased synthesis from the placenta as well as increased synthesis in the liver induced by large amounts of estrogens.[10][11][12] Levels in the third trimester can be as much as 2-fold greater than in non-pregnant women.[10] As a result, ALP is not a reliable marker of hepatic function in pregnant women.[10] In contrast to ALP, levels of ALT, AST, GGT, and lactate dehydrogenase are only slightly changed or largely unchanged during pregnancy.[10] Bilirubin levels are significantly decreased in pregnancy.[10]
In pregnancy conditions such as hyperemesis gravdirum, ALP levels can reach 215 IU/L, meanwhile, in pre-eclampsia, ALP can reach 14 IU/L, and in HELLP syndrome ALP levels can reach 15 IU/L.[6]
Gamma-glutamyltransferase (GGT)
Reference range |
9 to 85 IU/L[6] |
GGT is a microsomal enzyme found in hepatocytes, biliary epithelial cells, renal tubules, pancreas, and intestines. It helps in glutathione metabolism by transporting peptides across the cell membrane. Much like ALP, GGT measurements are usually elevated if cholestasis is present.[9] In acute viral hepatitis, the GGT levels can peak at 2nd and 3rd week of illness, and remained elevated at 6 weeks of illness. GGT is also elevated in 30% of the hepatitis C patients. GGT can increase by 10 times in alcoholism. GGT can increase by 2 to 3 times in 50% of the patients with non-alcoholic liver disease. When GGT levels is elevated, the triglyceride level is elevated also. With insulin treatment, the GGT level can reduce. Other causes of elevated GGT are: diabetes mellitus, acute pancreatitis, myocardial infarction, anorexia nervosa, Guillain–Barré syndrome, hyperthyroidism, obesity and myotonic dystrophy.[6]
In pregnancy conditions GGT activity is reduced in 2nd and 3rd trimesters. In hyperemesis gravidarum, GGT level value can reach 45 IU/L, 17 IU/L in pre-eclampsia, and 35 IU/L in HELPP syndrome.[6]
Albumin
Reference range
|
3.5 to 5.3 g/dL |
Other tests
Other tests are requested alongside LFT to rule out specific causes.
5' Nucleotidase
Reference range |
0 to 15 IU/L[6] |
5' Nucleotidase (5NT) is a glycoprotein found throughout the body, in the cytoplasmic membrane, catalyzing the conversion to inorganic phosphates from nucleoside-5-phosphate. Its level is raised in conditions such as obstructive jaundice, parenchymal liver disease, liver metastases, and bone disease.[6]
Serum NT levels are higher during 2nd and 3rd trimesters in pregnancy.[6]
Ceruloplasmin
Reference range |
200–600 mg/L[6] |
Ceruloplasmin is an
Alpha-fetoprotein
Reference range |
0-15 μg/L[6] |
Alpha-fetoprotein (AFP) is significantly expressed in foetal liver. However, the mechanism that led to the suppression of AFP synthesis in adults is not fully known. Exposure of the liver to cancer-causing agents and arrest of liver maturation in childhood can lead to the rise in AFP. AFP can reach until 400–500 μg/L in hepatocellular carcinoma. AFP concentration of more than 400 μg/L is associated with greater tumour size, involvement of both lobes of liver, portal vein invasion and a lower median survival rate.[6]
Coagulation test
The liver is responsible for the production of the vast majority of
Prothrombin time (PT) and its derived measures of prothrombin ratio (PR) and INR are measures of the extrinsic pathway of coagulation. This test is also called "ProTime INR" and "INR PT". They are used to determine the clotting tendency of blood, in the measure of warfarin dosage, liver damage, and vitamin K status.[15]
Serum glucose
The serum glucose test, abbreviated as "BG" or "Glu", measures the liver's ability to produce glucose (
Lactate dehydrogenase
Lactate dehydrogenase (LDH) is found in many body tissues, including the liver. Elevated levels of LDH may indicate liver damage.[17] LDH isotype-1 (or cardiac) is used for estimating damage to cardiac tissue, although troponin and creatine kinase tests are preferred.[18]
See also
- Reference ranges for blood tests
- Elevated transaminases
- Liver disorders
- Child–Pugh score
References
- ISBN 978-1-58528-180-0. Retrieved 5 August 2011.
- PMID 10221307.
- ISBN 978-0-683-30751-1.
- ISBN 978-0-07-142322-9.
- S2CID 23788795.
- ^ PMID 21532726.
- ^ PMID 25647209.
- PMID 27398328.
- ^ OCLC 990065894.
- ^ ISBN 978-1-4684-9862-2.
- ISBN 978-1-4613-2972-5.
- PMID 14236214.
- S2CID 45694428.
- ^ "Prealbumin Blood Test: MedlinePlus Medical Test". medlineplus.gov. Retrieved 25 February 2021.
- ^ "Prothrombin Time Test and INR (PT/INR): MedlinePlus Medical Test". medlineplus.gov. Retrieved 25 February 2021.
- ^ Kingston, Hannah. "Liver Function Test: How Often Should you Check Your Liver Function?". LetsGetChecked.
- ^ "Lactate Dehydrogenase (LDH) Test: MedlinePlus Medical Test". medlineplus.gov. Retrieved 25 February 2021.
- PMID 14659867.
External links
- Liver Function Tests at the U.S. National Library of Medicine Medical Subject Headings (MeSH)
- Liver Function Tests at Lab Tests Online
- Overview at Mayo Clinic
- Abnormal Liver Function Tests Archived 11 April 2012 at the Wayback Machine
- Overview of liver enzymes
- Abnormal Liver Tests Curriculum at AASLD
- Further workup of abnormal liver tests: "etiology panel"